Organogenesis Withdraws Previously Announced FY23 Guidance, Originally Issued On May 10, 2023
Portfolio Pulse from Benzinga Newsdesk
Organogenesis has withdrawn its FY23 guidance, originally issued on May 10, 2023, due to the unpredictability of the impact of recently published local coverage determinations on its financial position and operating results.
August 09, 2023 | 8:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Organogenesis has withdrawn its FY23 guidance due to uncertainty over the impact of recent local coverage determinations. This could potentially affect the company's financial position and operating results.
The withdrawal of the FY23 guidance indicates uncertainty in the company's future financial performance. This could potentially lead to a negative market reaction, impacting the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100